neurocare Raises EUR 19.3M in Funding
Summary
The company intends to use the funds to further develop its technologies and services as well as expand its international footprint of mental health clinics. Led by CEO Thomas Mechtersheimer, neurocare provides a mental health platform that empowers clinicians to provide personalized treatment for a range of psychological or neurological conditions. It integrates innovative mental health care methods and tools such as sleep hygiene, rTMS, QEEG and neurofeedback with existing approaches such as talk therapy and pharmaceuticals. These assets are all embedded within a cloud-based solution to drive productivity and improve outcomes. Following a detailed assessment of the patient’s condition, it supports clinicians in developing individualized therapy plans, scientifically proven to deliver superior clinical outcomes for Depression, ADHD, mental performance and other indications.